|
1.
|
Choi YW, Choi JS, Zheng LT, et al:
Comparative genomic hybridization array analysis and real time PCR
reveals genomic alterations in squamous cell carcinomas of the
lung. Lung Cancer. 55:43–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Travis WD, Brambilla E, Muller-Hermelink
HK and Harris CC: World Health Organization Classification of
Tumors. Pathology and Genetics of the Lung, Pleura, Thymus and
Heart. IARC Press; Lyon: 2004
|
|
3.
|
Spira A and Ettinger DS: Multidisciplinary
management of lung cancer. N Engl J Med. 350:379–392. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Salgia R, Hensing T, Campbell N, et al:
Personalized treatment of lung cancer. Semin Oncol. 38:274–283.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Parkin DM, Bray FI and Devesa SS: Cancer
burden in the year 2000. The global picture. Eur J Cancer. 37(Suppl
8): S4–S66. 2001.PubMed/NCBI
|
|
6.
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
7.
|
Moran C: Importance of molecular features
of non-small cell lung cancer for choice of treatment. Am J Pathol.
178:1940–1948. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Hoffman PC, Mauer AM and Vokes EE: Lung
cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Hess KR, Varadhachary GR, Taylor SH, et
al: Metastatic patterns in adenocarcinoma. Cancer. 106:1624–1633.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Feld R, Rubinstein LV and Weisenberger TH:
Sites of recurrence in resected stage I non-small-cell lung cancer:
a guide for future studies. J Clin Oncol. 2:1352–1358.
1984.PubMed/NCBI
|
|
11.
|
Bernards R and Weinberg RA: A progression
puzzle. Nature. 418:8232002. View
Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Wang Y, Moorhead M, Karlin-Neumann G, et
al: Allele quantification using molecular inversion probes (MIP).
Nucleic Acids Res. 33:e1832005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Johnson CE, Gorringe KL, Thompson ER, et
al: Identification of copy number alterations associated with the
progression of DCIS to invasive ductal carcinoma. Breast Cancer Res
Treat. 133:889–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Schiffman JD, Wang Y, McPherson LA, et al:
Molecular inversion probes reveal patterns of 9p21 deletion and
copy number aberrations in childhood leukemia. Cancer Genet
Cytogenet. 193:9–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wang Y, Moorhead M, Karlin-Neumann G, et
al: Analysis of molecular inversion probe performance for allele
copy number determination. Genome Biol. 8:R2462007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Travis WD and Rekhtman N: Pathological
diagnosis and classification of lung cancer in small biopsies and
cytology: strategic management of tissue for molecular testing.
Semin Respir Crit Care Med. 32:22–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Travis WD, Rekhtman N, Riley GJ, et al:
Pathologic diagnosis of advanced lung cancer based on small
biopsies and cytology: a paradigm shift. J Thorac Oncol. 5:411–414.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kang JU, Koo SH, Kwon KC, Park JW and Kim
JM: Identification of novel candidate target genes, including
EPHB3, MASP1 and SST at 3q26.2–q29 in squamous cell carcinoma of
the lung. BMC Cancer. 9:2372009.PubMed/NCBI
|
|
19.
|
Yokoi S, Yasui K, Iizasa T, Imoto I,
Fujisawa T and Inazawa J: TERC identified as a probable target
within the 3q26 amplicon that is detected frequently in non-small
cell lung cancers. Clin Cancer Res. 9:4705–4713. 2003.PubMed/NCBI
|
|
20.
|
Ubagai T, Matsuura S, Tauchi H, Itou K and
Komatsu K: Comparative genomic hybridization analysis suggests a
gain of chromosome 7p associated with lymph node metastasis in
non-small cell lung cancer. Oncol Rep. 8:83–88. 2001.PubMed/NCBI
|
|
21.
|
Kang JU, KS, Kwon KC, Park JW, Shin SY,
Kim JM and Jung SS: High frequency of genetic alterations in
non-small cell lung cancer detected by multi-target fluorescence in
situ hybridization. J Korean Med Sci. 22:47–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Dehan E, Ben-Dor A, Liao W, et al:
Chromosomal aberrations and gene expression profiles in non-small
cell lung cancer. Lung Cancer. 56:175–184. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Chujo M, Noguchi T, Miura T, Arinaga M,
Uchida Y and Tagawa Y: Comparative genomic hybridization analysis
detected frequent overrepresentation of chromosome 3q in squamous
cell carcinoma of the lung. Lung Cancer. 38:23–29. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Kang JU, Koo SH, Kwon KC, Park JW and Jung
SS: Gain of the EGFR gene located on 7p12 is a frequent and early
event in squamous cell carcinoma of the lung. Cancer Genet
Cytogenet. 184:31–37. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Massion PP, Kuo WL, Stokoe D, et al:
Genomic copy number analysis of non-small cell lung cancer using
array comparative genomic hybridization: implications of the
phosphatidylinositol 3-kinase pathway. Cancer Res. 62:3636–3640.
2002.
|
|
26.
|
Kikuchi T, Daigo Y, Ishikawa N, et al:
Expression profiles of metastatic brain tumor from lung
adenocarcinomas on cDNA microarray. Int J Oncol. 28:799–805.
2006.PubMed/NCBI
|
|
27.
|
Robnett TJ, Machtay M, Stevenson JP,
Algazy KM and Hahn SM: Factors affecting the risk of brain
metastases after definitive chemo-radiation for locally advanced
non-small-cell lung carcinoma. J Clin Oncol. 19:1344–1349.
2001.PubMed/NCBI
|
|
28.
|
Grinberg-Rashi H, Ofek E, Perelman M, et
al: The expression of three genes in primary non-small cell lung
cancer is associated with metastatic spread to the brain. Clin
Cancer Res. 15:1755–1761. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Oh Y, Taylor S, Bekele BN, et al: Number
of metastatic sites is a strong predictor of survival in patients
with nonsmall cell lung cancer with or without brain metastases.
Cancer. 115:2930–2938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Tam IY, Chung LP, Suen WS, et al: Distinct
epidermal growth factor receptor and KRAS mutation patterns in
non-small cell lung cancer patients with different tobacco exposure
and clinicopathologic features. Clin Cancer Res. 12:1647–1653.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Mok TS, Wu YL, Thongprasert S, et al:
Gefitinib or carboplatinpaclitaxel in pulmonary adenocarcinoma. N
Engl J Med. 361:947–957. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Shaw AT, Yeap BY, Mino-Kenudson M, et al:
Clinical features and outcome of patients with non-small-cell lung
cancer who harbor EML4-ALK. J Clin Oncol. 27:4247–4253. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Scagliotti G, Brodowicz T, Shepherd FA, et
al: Treatment-byhistology interaction analyses in three phase III
trials show superiority of pemetrexed in nonsquamous non-small cell
lung cancer. J Thorac Oncol. 6:64–70. 2011.PubMed/NCBI
|
|
34.
|
Chansky K, Sculier JP, Crowley JJ, Giroux
D, Van Meerbeeck J and Goldstraw P: The International Association
for the Study of Lung Cancer Staging Project: prognostic factors
and pathologic TNM stage in surgically managed non-small cell lung
cancer. J Thorac Oncol. 4:792–801. 2009. View Article : Google Scholar
|
|
35.
|
Pisters KM, Evans WK, Azzoli CG, et al:
Cancer Care Ontario and American Society of Clinical Oncology
adjuvant chemotherapy and adjuvant radiation therapy for stages
I–IIIA resectable non-small-cell lung cancer guideline. J Clin
Oncol. 25:5506–5518. 2007.PubMed/NCBI
|
|
36.
|
Bass AJ, Watanabe H, Mermel CH, et al:
SOX2 is an amplified lineage-survival oncogene in lung and
esophageal squamous cell carcinomas. Nat Genet. 41:1238–1242. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Rullinkov G, Tamme R, Sarapuu A, et al:
Neuralized-2: expression in human and rodents and interaction with
Delta-like ligands. Biochem Biophys Res Commun. 389:420–425. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Song R, Koo BK, Yoon KJ, et al:
Neuralized-2 regulates a Notch ligand in cooperation with Mind
bomb-1. J Biol Chem. 281:36391–36400. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Collins BJ, Kleeberger W and Ball DW:
Notch in lung development and lung cancer. Semin Cancer Biol.
14:357–364. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Westhoff B, Colaluca IN, D’Ario G, et al:
Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci
USA. 106:22293–22298. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Yang Y, Ahn YH, Gibbons DL, et al: The
Notch ligand Jagged2 promotes lung adenocarcinoma metastasis
through a miR-200-dependent pathway in mice. J Clin Invest.
121:1373–1385. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Peter ME, Budd RC, Desbarats J, et al: The
CD95 receptor: apoptosis revisited. Cell. 129:447–450. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Peter ME, Legembre P and Barnhart BC: Does
CD95 have tumor promoting activities? Biochim Biophys Acta.
1755:25–36. 2005.PubMed/NCBI
|
|
44.
|
Mitsiades CS, Poulaki V, Fanourakis G, et
al: Fas signaling in thyroid carcinomas is diverted from apoptosis
to proliferation. Clin Cancer Res. 12:3705–3712. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Barnhart BC, Legembre P, Pietras E, Bubici
C, Franzoso G and Peter ME: CD95 ligand induces motility and
invasiveness of apoptosis-resistant tumor cells. EMBO J.
23:3175–3185. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Chen L, Park SM, Tumanov AV, et al: CD95
promotes tumour growth. Nature. 465:492–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Zhang Y, Liu Q, Zhang M, Yu Y, Liu X and
Cao X: Fas signal promotes lung cancer growth by recruiting
myeloid-derived suppressor cells via cancer cell-derived PGE2. J
Immunol. 182:3801–3808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Kleber S, Sancho-Martinez I, Wiestler B,
et al: Yes and PI3K bind CD95 to signal invasion of glioblastoma.
Cancer Cell. 13:235–248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Masszi A, Speight P, Charbonney E, et al:
Fate-determining mechanisms in epithelial-myofibroblast transition:
major inhibitory role for Smad3. J Cell Biol. 188:383–399. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Wang J, Zohar R and McCulloch CA: Multiple
roles of alpha-smooth muscle actin in mechanotransduction. Exp Cell
Res. 312:205–214. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Han M, Liu M, Wang Y, et al: Re-expression
of miR-21 contributes to migration and invasion by inducing
epithelial-mesenchymal transition consistent with cancer stem cell
characteristics in MCF-7 cells. Mol Cell Biochem. 363:427–436.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Owens GK and Thompson MM: Developmental
changes in isoactin expression in rat aortic smooth muscle cells in
vivo. Relationship between growth and cytodifferentiation. J Biol
Chem. 261:13373–13380. 1986.PubMed/NCBI
|
|
53.
|
Pirozzi G, Tirino V, Camerlingo R, et al:
Epithelial to mesenchymal transition by TGFbeta-1 induction
increases stemness characteristics in primary non-small cell lung
cancer cell line. PLoS One. 6:e215482011. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Valcz G, Sipos F, Krenacs T, et al:
Increase of alpha-SMA(+) and CK (+) cells as an early sign of
epithelial-mesenchymal transition during colorectal carcinogenesis.
Pathol Oncol Res. 18:371–376. 2012.
|
|
55.
|
Perez OD, Kinoshita S, Hitoshi Y, et al:
Activation of the PKB/AKT pathway by ICAM-2. Immunity. 16:51–65.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Fidler IJ: The pathogenesis of cancer
metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003.
|
|
57.
|
Ji H, Kumm J, Zhang M, et al: Molecular
inversion probe analysis of gene copy alterations reveals distinct
categories of colorectal carcinoma. Cancer Res. 66:7910–7919. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Lapuk A, Volik S, Vincent R, et al:
Computational BAC clone contig assembly for comprehensive genome
analysis. Genes Chromosomes Cancer. 40:66–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Wang Y, Carlton VE, Karlin-Neumann G, et
al: High quality copy number and genotype data from FFPE samples
using Molecular Inversion Probe (MIP) microarrays. BMC Med
Genomics. 2:82009. View Article : Google Scholar : PubMed/NCBI
|
